+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Proton pump inhibitors do not increase the risk for recurrent spontaneous bacterial peritonitis in patients with cirrhosis



Proton pump inhibitors do not increase the risk for recurrent spontaneous bacterial peritonitis in patients with cirrhosis



Journal of Gastroenterology and Hepatology 32(5): 1064-1070



The present study aimed to assess the real impact of proton pump inhibitor (PPI) use on incidence of recurrent spontaneous bacterial peritonitis (SBP) in a homogenous population composed of cirrhotic patients with a previous SBP where differences related with SBP incidence between PPI users and non-users are less likely to exist. This retrospective cohort study enrolled 307 cirrhotic patients taking diuretics for ascites control and had a previous SBP. Patients who took any PPI for at least 1 week prior to a second SBP were included in the PPI group. The incidence of a second SBP was a primary outcome and was compared between PPI group and non-PPI group before and after propensity score matching. Risk factors for a second SBP were investigated by multivariate analysis. Second SBP occurred in 17 patients (29.3%) during mean 52.1 ± 5.2 months of PPI group and in 60 patients (24.1%) during mean 61.9 ± 4.8 months of non-PPI group, which did not differ (P = .185). In the matched cohort, second SBP similarly occurred in both groups [29.3% of PPI group vs 26.8% of non-PPI group (P = .271)]. According to the multivariate analysis, Child-Pugh score was the only significant risk factor for a second SBP (hazard ratio 1.68, 95% confidence interval, 1.13-2.50, P = .001). Isolated bacteria and clinical outcomes such as of mortality, presence of sepsis, and hospital stay did not differ between the two groups in the matched cohort. Proton pump inhibitor use is not a risk factor for recurrent SBP in cirrhotic patients.

(PDF emailed within 0-6 h: $19.90)

Accession: 060148680

Download citation: RISBibTeXText

PMID: 28449345

DOI: 10.1111/jgh.13637


Related references

Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites. Hepatology 64(4): 1265-1272, 2017

Effect of Proton Pump Inhibitors on Mortality in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis. Annals of Hepatology 17(6): 933-939, 2019

Increased Risk of Spontaneous Bacterial Peritonitis in Cirrhotic Patients Using Proton Pump Inhibitors. Ge Portuguese Journal of Gastroenterology 26(2): 83-89, 2019

Proton Pump Inhibitors Increase the Overall Risk of Developing Bacterial Infections in Patients with Cirrhosis. Arquivos de Gastroenterologia 55(1): 28-32, 2018

Are proton pump inhibitors a threat for spontaneous bacterial peritonitis and hepatic encephalopathy in cirrhosis? Not so fast. Hepatology 65(1): 393, 2016

Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: a multicenter prospective study. Journal of Hepatology 62(5): 1056-1060, 2016

Proton pump inhibitor use significantly increases the risk of spontaneous bacterial peritonitis in 1965 patients with cirrhosis and ascites: a propensity score matched cohort study. Alimentary Pharmacology and Therapeutics 40(6): 695-704, 2014

Proton pump inhibitor use is associated with spontaneous bacterial peritonitis in patients with liver cirrhosis. Internal Medicine 53(10): 1037-1042, 2015

Proton pump inhibitor use and association with spontaneous bacterial peritonitis in patients with cirrhosis and ascites. Annals of PharmacoTherapy 46(10): 1413-1418, 2013

Mortality associated with proton pump inhibitors in cirrhotic patients with spontaneous bacterial peritonitis. Journal of Gastroenterology and Hepatology 29(4): 775-781, 2014

Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascites. Plos One 9(11): E110503, 2015

Role of proton pump inhibitors in the occurrence and the prognosis of spontaneous bacterial peritonitis in cirrhotic patients with ascites. Liver International 33(9): 1316-1323, 2014

Association between proton pump inhibitors and spontaneous bacterial peritonitis in cirrhotic patients - a systematic review and meta-analysis. International Journal of Clinical Practice 65(6): 674-678, 2012

Proton pump inhibitor use and spontaneous bacterial peritonitis in cirrhosis: An undesirable association?. Journal of Hepatology 63(2): 529-530, 2016

Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study. Gastroenterology 152(1): 134-141, 2016